CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Sanofi

SNY
$115.30B
Large Cap
NASDAQBiotechnology🇫🇷Europe82.9K employees
Website

Drugs in Pipeline

544

Phase 3 Programs

346

Upcoming Catalysts

29

Next Catalyst

Feb 25, 2026

17d
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Market Overview

Stock performance and market intelligence

Catalyst Timeline

29 upcoming, 0 past

Phase 2Next

SAR443122 Phase 2 Results Expected

Feb 25, 2026SAR443122182

Primary completion for SAR443122 trial (NCT05588843) in Colitis Ulcerative

Source
⭐Phase 3

avalglucosidase alfa Phase 3 Results Expected

Mar 6, 2026avalglucosidase alfa17

Primary completion for avalglucosidase alfa trial (NCT04910776) in Glycogen Storage Disease Type II

Source
Phase 2

Lunsekimig Phase 2 Results Expected

Mar 23, 2026lunsekimig64

Primary completion for Lunsekimig trial (NCT06102005) in Asthma

Source
Phase 2

Pandemic flu H5 mRNA vaccine Phase 2 Results Expected

Mar 31, 2026Pandemic flu H5 mRNA vaccine276

Primary completion for Pandemic flu H5 mRNA vaccine trial (NCT06727058) in Influenza Immunization

Source
Phase 2

IIV-HD Phase 2 Results Expected

Apr 1, 2026IIV-HD

Primary completion for IIV-HD trial (NCT06695117) in COVID-19 Immunization

Source
Phase 2

Sarilumab SAR153191 (REGN88) Phase 2 Results Expected

Apr 1, 2026Sarilumab SAR153191 (REGN88)51

Primary completion for Sarilumab SAR153191 (REGN88) trial (NCT02991469) in Juvenile Idiopathic Arthritis

Source
Phase 2

RIV (recombinant influenza vaccine) Phase 2 Results Expected

Apr 3, 2026RIV (recombinant influenza vaccine)

Primary completion for RIV (recombinant influenza vaccine) trial (NCT06695130) in COVID-19 Immunization

Source
⭐Phase 3

Isatuximab SAR650984 Phase 3 Results Expected

Apr 5, 2026Isatuximab SAR650984475

Primary completion for Isatuximab SAR650984 trial (NCT03319667) in Plasma Cell Myeloma

Source
⭐Phase 3

Bortezomib Phase 3 Results Expected

Apr 5, 2026Bortezomib475

Primary completion for Bortezomib trial (NCT03319667) in Plasma Cell Myeloma

Source
⭐Phase 3

Low Dose (LD) RSVt vaccine Phase 3 Results Expected

Apr 17, 2026Low Dose (LD) RSVt vaccine947

Primary completion for Low Dose (LD) RSVt vaccine trial (NCT06705140) in RSV Immunisation

Source
⭐Phase 3

Venglustat (GZ402671) Phase 3 Results Expected

May 15, 2026Venglustat (GZ402671)

Primary completion for Venglustat (GZ402671) trial (NCT05280548) in Fabry Disease

Source
⭐Phase 3

RSVt Vaccine Phase 3 Results Expected

May 27, 2026RSVt vaccine6,300

Primary completion for RSVt Vaccine trial (NCT06252285) in RSV Immunisation

Source
Phase 2

Pandemic flu H5 HA mRNA SD2 vaccine Phase 2 Results Expected

May 28, 2026Pandemic flu H5 HA mRNA SD2 vaccine

Primary completion for Pandemic flu H5 HA mRNA SD2 vaccine trial (NCT06907511) in Pandemic Influenza Immunization

Source
Phase 2

SAR441344 IV Phase 2 Results Expected

Jul 10, 2026SAR441344 IV116

Primary completion for SAR441344 IV trial (NCT05039840) in Systemic Lupus Erythematosus

Source
Phase 2

Amlitelimab Phase 2 Results Expected

Aug 4, 2026Amlitelimab204

Primary completion for Amlitelimab trial (NCT06557772) in Coeliac Disease

Source
⭐Phase 3

Yellow fever vaccine (live) Phase 3 Results Expected

Aug 8, 2026Yellow fever vaccine (live)640

Primary completion for Yellow fever vaccine (live) trial (NCT07103148) in Yellow Fever Immunization

Source
⭐Phase 3

Measles, combinations with mumps and rubella, live attenuated Phase 3 Results Expected

Aug 8, 2026Measles, combinations with mumps and rubella, live attenuated

Primary completion for Measles, combinations with mumps and rubella, live attenuated trial (NCT07103148) in Yellow Fever Immunization

Source
Phase 2

Rilzabrutinib dose 1 Phase 2 Results Expected

Aug 25, 2026Rilzabrutinib dose 130

Primary completion for Rilzabrutinib dose 1 trial (NCT06984627) in Graves' Disease

Source
Phase 2

Belumosudil Phase 2 Results Expected

Aug 31, 2026Belumosudil36

Primary completion for Belumosudil trial (NCT05567406) in Chronic Graft Versus Host Disease

Source
⭐Phase 3

Fitusiran Phase 3 Results Expected

Nov 5, 2026Fitusiran281

Primary completion for Fitusiran trial (NCT03754790) in Hemophilia

Source
Phase 2

Isatuximab intravenous (IV) Phase 2 Results Expected

Nov 30, 2026Isatuximab intravenous (IV)70

Primary completion for Isatuximab intravenous (IV) trial (NCT05669989) in Plasma Cell Myeloma

Source
⭐Phase 3

PCV21 Phase 3 Results Expected

Dec 1, 2026PCV211,268

Primary completion for PCV21 trial (NCT06838000) in Pneumococcal Infections

Source
⭐Phase 3

Itepekimab (SAR440340) Phase 3 Results Expected

Dec 1, 2026Itepekimab (SAR440340)

Primary completion for Itepekimab (SAR440340) trial (NCT06208306) in Chronic Obstructive Pulmonary Disease

Source
Phase 2

SAR442970 Phase 2 Results Expected

Dec 17, 2026SAR44297099

Primary completion for SAR442970 trial (NCT06958536) in Crohn's Disease

Source
⭐Phase 3

MRI contrast-enhancing agents Phase 3 Results Expected

Dec 23, 2026MRI contrast-enhancing agents

Primary completion for MRI contrast-enhancing agents trial (NCT06141486) in Multiple Sclerosis

Source
⭐Phase 3

Frexalimab Phase 3 Results Expected

Dec 23, 2026Frexalimab

Primary completion for Frexalimab trial (NCT06141486) in Multiple Sclerosis

Source
Phase 2

Isatuximab SC-OBDS Phase 2 Results Expected

Jan 8, 2027Isatuximab SC-OBDS64

Primary completion for Isatuximab SC-OBDS trial (NCT06356571) in Plasma Cell Myeloma Refractory

Source
⭐Phase 3

Mometasone furoate nasal spray (MFNS) Phase 3 Results Expected

Jan 8, 2027Mometasone furoate nasal spray (MFNS)210

Primary completion for Mometasone furoate nasal spray (MFNS) trial (NCT06834360) in Chronic Rhinosinusitis With Nasal Polyps

Source
⭐Phase 3

efanesoctocog alfa (BIVV001) Phase 3 Results Expected

Jan 15, 2027efanesoctocog alfa (BIVV001)261

Primary completion for efanesoctocog alfa (BIVV001) trial (NCT04644575) in Hemophilia A

Source

AI Predictions & Institutional Flow

Machine learning insights and smart money movement

FDA Submissions

Pending NDA/BLA submissions with predicted PDUFA dates

Drug Pipeline

Clinical development programs and drug candidates

Drug Pipeline

lunsekimig

Phase 3

Chronic Rhinosinusitis With Nasal Polyps

Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis)

Phase 3

Tetanus

Venglustat (GZ402671)

Phase 3

Fabry Disease

triamcinolone XRG5029

Phase 3

Rhinitis Allergic

lormetazepam

Phase 3

Sleep Initiation and Maintenance Disorders

5-fluorouracil

Phase 3

Breast Cancer

DTaP-IPV//PRP~T combined vaccine

Phase 3

Diphtheria

Telithromycin (HMR3647)

Phase 3

Pneumonia

Topical corticosteroids

Phase 3

Dermatitis Atopic

Insulin Aspart SAR341402

Phase 3

Type 1 Diabetes Mellitus

Plerixafor

Phase 3

Multiple Myeloma

volinanserin (M100907)

Phase 3

Sleep Initiation and Maintenance Disorders

Pemetrexed

Phase 3

Non Small Cell Lung Cancer

BIVV009

Phase 3

Agglutinin Disease, Cold

irbesartan/amlodipine

Phase 3

Hypertension

Lipid Modifying Therapy (LMT)

Phase 3

Hypercholesterolemia

SR121463B

Phase 3

Inappropriate ADH Syndrome

Inactivated Split-virion influenza vaccine

Phase 3

Orthomyxoviridae Infection

PCV21

Phase 3

Pneumococcal Infections

Dermacyd PH_DETINLYN (Lactic Acid)

Phase 3

Hygiene

Influenza virus vaccine (split virion, inactivated)

Phase 3

Influenza

MenACYW conjugate vaccine

Phase 3

Meningococcal Infections

Typhoid Vi polysaccharide

Phase 3

Salmonella Infections

ketoprofen 100 mg

Phase 3

Pain

risedronate (HMR4003)

Phase 3

Osteoporosis, Postmenopausal

Diphtheria, tetanus, polio and pertussis vaccination

Phase 3

Diphtheria

REVAXIS®

Phase 3

Diphtheria

Mometasone furoate nasal spray (MFNS)

Phase 3

Chronic Rhinosinusitis With Nasal Polyps

Lantus (Insulin glargine)

Phase 3

Type 2 Diabetes Mellitus

Dupilumab SAR231893 (REGN668)

Phase 3

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)

Ezetimibe

Phase 3

Hypercholesterolemia

fexofenadine/Allegra (M016455)

Phase 3

Atopic Dermatitis

Cetylpyridinium chloride

Phase 3

Hygiene

DTaP-IPV-Hep B-PRP~T combined vaccine + Pneumococcal polysaccharide

Phase 3

Diphtheria

Hexaxim™: DTaP-IPV-Hep B-PRP~T combined vaccine

Phase 3

Diphtheria

ChimeriVax-JE, Japanese Encephalitis vaccine

Phase 3

Encephalitis

REPEVAX® after REVAXIS®

Phase 3

Healthy Adult

CombAct-HIB®

Phase 3

Hepatitis B

Alfuzosin (SL770499)

Phase 3

Urinary Retention

Pioglitazone

Phase 3

Diabetes Mellitus Type 2

volinanserin

Phase 3

Sleep Initiation and Maintenance Disorders

clopidogrel (SR25990)

Phase 3

Stable Angina

Human Papillomavirus Bivalent [Types 16 and 18] Vaccine, Recombinant

Phase 3

Dengue Fever

Irinotecan

Phase 3

Carcinoma, Non-Small-Cell Lung

Lantus (insulin glargine [rDNA origin] injection)

Phase 3

Diabetes Mellitus

Lactic acid (Dermacyd Femina)

Phase 3

Hygiene

Frexalimab

Phase 3

Type 1 Diabetes Mellitus

XRP6976 (Docetaxel/Taxotere)

Phase 3

Cancer

Diphteria/Tetanus/Polio/Acellular Pertussis/Hib vaccine

Phase 3

Diphtheria

Isatuximab IV

Phase 3

Plasma Cell Myeloma Recurrent

Generic = Plerixafor

Phase 3

Lymphoma (Non-Hodgkin's Lymphoma)

amlodipine

Phase 3

Hypertension

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®)

Phase 3

Meningitis

DAPTACEL®: DTaP

Phase 3

Diphtheria

Dermacyd PH_DETINBACK (Lactic Acid)

Phase 3

Hygiene

Piperacillin/Tazobactam

Phase 3

Pneumonia

MenACYW-135 conjugate vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Multi-dose Quadrivalent Influenza Vaccine

Phase 3

Influenza

Docetaxel (XRP6976)

Phase 3

Prostate Cancer

Methotrexate

Phase 3

Uveitis

Folic acid

Phase 3

Rheumatoid Arthritis

Mometasone furoate nasal spray

Phase 3

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)

Glimepiride+metformin (Amaryl M®) - HOE4900

Phase 3

Type 2 Diabetes Mellitus

Leflunomide

Phase 3

Systemic Lupus Eythematosus (SLE)

Inactivated Poliomyelitis vaccine

Phase 3

Poliomyelitis

SR57746A

Phase 3

Metastases

DTaP-IPV-Hep B-PRP-T Vaccine

Phase 3

Diphtheria

rimonabant

Phase 3

Smoking Cessation

VRVg-2

Phase 3

Rabies (Healthy Volunteers)

HOE901-U300 (new formulation of insulin glargine)

Phase 3

Type 2 Diabetes Mellitus

DTaP-IPV/Hib Combined vaccine

Phase 3

Tetanus

Purified vero rabies vaccine - serum free

Phase 3

Rabies (Healthy Volunteers)

Japanese encephalitis chimeric virus: Measles, mumps, and rubella live attenuated virus

Phase 3

Japanese Encephalitis

DTaP-IPV-HB-PRP~T and Pneumococcal polysaccharide vaccines

Phase 3

Hepatitis B

TdcP-IPV vaccine

Phase 3

Diphtheria

pristinamycin

Phase 3

Tonsillitis

KETOPROFEN(RP19583)

Phase 3

Pain

5-fluorouracil (5-FU)

Phase 3

Head and Neck Neoplasms

Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine

Phase 3

Meningococcal Infection

Neutral Protamine Hagedorn (NPH) insulin

Phase 3

Type 1 Diabetes Mellitus

Telithromycin

Phase 3

Maxillary Sinusitis

fexofenadine HCL (M016455)

Phase 3

Rhinitis Seasonal

Simvastatin

Phase 3

Hypercholesterolemia

Eplivanserin

Phase 3

Sleep Initiation and Maintenance Disorders

Measles-mumps-rubella-varicella vaccine

Phase 3

Meningococcal Meningitis

PENTAXIM™: DTacP IPV//PRP~T combined vaccine

Phase 3

Diphtheria

hydroxychloroquine

Phase 3

Rheumatoid Arthritis

Meningococcal Polysaccharide Diphtheria Conjugate Vaccine

Phase 3

Meningococcal Meningitis

SODIUM DIVALPROATE

Phase 3

Bipolar Disorder

Dermacid Silver (Lactic acid)

Phase 3

Hygiene

Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

Phase 3

Meningitis

Influenza Virus Vaccine USP Quadrivalent, (Zonal Purified Subvirion) 2012 2013 Formulation

Phase 3

Influenza

Fexofenadine (loratadine if not available)

Phase 3

Pruritus

gemcitabine/carboplatin

Phase 3

Squamous Cell Lung Cancer

gemcitabine

Phase 3

Non-small Cell Lung Cancer Stage IV

Satavaptan

Phase 3

Ascites

Sevelamer carbonate

Phase 3

Chronic Kidney Disease

SAR342434

Phase 3

Type 2 Diabetes Mellitus

HUMAN INSULIN (BIOSYNTHETIC)

Phase 3

Diabetes Mellitus, Type 1

somatropine

Phase 3

Growth Hormone Deficiency

ticlopidine

Phase 3

Peripheral Arterial Disease (PAD)

Oxaliplatin (SR96669)

Phase 3

Colonic Neoplasms

ARTESUNATE + AMODIAQUINE

Phase 3

Malaria

Japanese encephalitis chimeric virus vaccine (JE-CV)

Phase 3

Encephalitis

risedronate

Phase 3

Osteoporosis

ciclesonide

Phase 3

Asthma

lixisenatide AVE0010

Phase 3

Type 2 Diabetes Mellitus

Insuline Glulisine

Phase 3

Diabetes Mellitus, Type 1

75% insulin lispro protamine suspension and 25 % insulin lispro injection

Phase 3

Diabetes Mellitus, Type 2

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®

Phase 3

Meningitis

Belumosudil

Phase 3

Chronic Graft Versus Host Disease

Aldurazyme (Recombinant Human Alpha-L-Iduronidase)

Phase 3

Mucopolysaccharidosis I

Dupilumab (SAR231893/REGN668)

Phase 3

Asthma

Insulin glargine new formulation (HOE901)

Phase 3

Type 2 Diabetes Mellitus

Lactic acid (Dermacyd Femina Delicata)

Phase 3

Hygiene

Myozyme

Phase 3

Pompe Disease (Late-onset)

JE-CV administered in Study JEC02

Phase 3

Encephalitis

Hepatitis A vaccine AVAXIM 80U

Phase 3

Hepatitis A

Flu-ID 15μg

Phase 3

Influenza

Irbesartan

Phase 3

Hypertension

DT5aP-IPV-Hib 5-component Pertussis vaccine

Phase 3

Infant

MRI contrast-enhancing agents

Phase 3

Multiple Sclerosis

AVANAFIL

Phase 3

Sexual Function and Fertility Disorders NEC-Erectile Dysfunction

Standard-Dose influenza virus surface antigens (haemagglutinin and neuraminidase), Inactivated, Influenza Vaccine Quadrivalent, 2019-2020 Northern Hemisphere Strains (QIV-SD)

Phase 3

Influenza Immunization

Purified inactivated rabies vaccine, serum free

Phase 3

Rabies

clofarabine (IV formulation)

Phase 3

Acute Myelogenous Leukemia

Irbesartan/hydrochlorothiazide

Phase 3

Hypertension

HOE901-U300 (Insulin glargine new formulation)

Phase 3

Type 1 Diabetes Mellitus

Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 virus

Phase 3

Dengue Fever

Otamixaban

Phase 3

Acute Coronary Syndrome

DTaP-HB-PRP~T vaccine + OPV

Phase 3

Diphtheria

paclitaxel

Phase 3

Uterine Carcinosarcoma

Warfarin

Phase 3

Embolism

Oral corticosteroid therapy (prednisone/prednisolone)

Phase 3

Asthma

ambroxol BIH1526

Phase 3

Pharyngitis

SR34006

Phase 3

Pulmonary Embolism

Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®)

Phase 3

Japanese Encephalitis

Inactive Poliovirus Vaccine

Phase 3

Poliomyelitis

HBVAXPRO 5µg

Phase 3

Virus Diseases

Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV)

Phase 3

Meningococcal Immunisation

sutimlimab (BIVV009)

Phase 3

Cold Agglutinin Disease

Antidiabetic background therapy

Phase 3

Type 2 Diabetes

Glucocorticoid

Phase 3

Immunoglobulin G4 Related Disease

Imiglucerase

Phase 3

Gaucher Disease, Type 1

Zolpidem (SL800750)

Phase 3

Attention Deficit Hyperactivity Disorder

Riliprubart

Phase 3

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Meningococcal Polysaccharide (Serogroups A,C,Y and W) Tetanus Toxoid Conjugate vaccine MenACYW conjugate vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

paroxetine

Phase 3

Depressive Disorder, Major

Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib

Phase 3

Diphtheria

Influenza Virus Vaccine USP Trivalent Types A and B

Phase 3

Orthomyxoviridae Infection

DTaP-IPV-Hep B- PRP~T + Prevenar + Rotarix vaccine

Phase 3

Diphtheria

Sulfonylurea

Phase 3

Type 2 Diabetes Mellitus

Quadrivalent Influenza Vaccine (split virion, inactivated)

Phase 3

Influenza

Prevnar 20 vaccine

Phase 3

Pneumococcal Immunization

Live, attenuated, dengue serotype 1, 2, 3, 4 virus

Phase 3

Dengue

Alirocumab SAR236553

Phase 3

Hypercholesterolaemia

CYD Dengue vaccine

Phase 3

Dengue Fever

Teriflunomide

Phase 3

Multiple Sclerosis

Avalglucosidase alfa (GZ402666)

Phase 3

Glycogen Storage Disease Type II;Pompe's Disease

Corticosteroids

Phase 3

Thrombotic Thrombocytopenic Purpura

Concomitant administration

Phase 3

Diphtheria

Diphteria, tetanus, and Acellular Pertussis vaccine

Phase 3

Diphtheria

docetaxel, doxorubicin, cyclophosphamide

Phase 3

Breast Cancer

teriflunomide HMR1726

Phase 3

Multiple Sclerosis

JE-CV Vaccine

Phase 3

Japanese Encephalitis

Insulin glargine,300 U/mL

Phase 3

Type 1 Diabetes Mellitus

Meningococcal Group C Conjugate vaccine: MenC

Phase 3

Meningitis

Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

Phase 3

Cholera

QIV-HD

Phase 3

Influenza

DTaP-IPV-HB-PRP~T vaccine

Phase 3

Diphtheria

Spores of Bacillus Clausii Probiotic Strain

Phase 3

Diarrhea

REPEVAX

Phase 3

Healthy

PEDIACEL® and Prevenar®

Phase 3

Diphtheria

Oral anti-diabetic drugs

Phase 3

Type 2 Diabetes Mellitus

Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed

Phase 3

Tetanus

Oxaliplatin

Phase 3

Carcinoma, Hepatocellular

ZD6474 (vandetanib)

Phase 3

Thyroid Cancer

Live, attenuated dengue serotype 1, 2, 3, and 4 virus

Phase 3

Dengue

SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1

Phase 3

COVID-19

acetylsalicyclic acid (ASA)

Phase 3

Acute Coronary Disease

High-Dose Quadrivalent Influenza Vaccine

Phase 3

Influenza (Healthy Volunteers)

Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Phase 3

Meningitis

Non sedating H1-antihistamine

Phase 3

Cold Urticaria

Meningococcal Diphtheria Toxoid Vaccine

Phase 3

Meningitis

Alfuzosin

Phase 3

Acute Urinary Retention

Budesonide

Phase 3

Chronic Rhinosinusitis With Nasal Polyps

HDCV

Phase 3

Healthy Volunteers (Rabies Immunization)

High-Dose trivalent influenza vaccine (Split virion, Inactivated)

Phase 3

Influenza

Quadrivalent Recombinant influenza vaccine (RIV4) season/2022-2023/NH

Phase 3

Influenza Immunization

Capecitabine

Phase 3

Stomach Neoplasms

DTaP//PRP-T Combined Vaccine

Phase 3

Diphtheria

Hexavalent vaccine

Phase 3

Neisseria Meningitidis

Prednisone

Phase 3

Chronic Graft Versus Host Disease

Rosuvastatin

Phase 3

Hypercholesterolemia

IMOJEV

Phase 3

Japanese Encephalitis

zolpidem-MR (modified release)

Phase 3

Sleep Initiation and Maintenance Disorders

Live attenuated Japanese encephalitis chimeric virus vaccine

Phase 3

Japanese Encephalitis

larotaxel (XRP9881)

Phase 3

Advanced Breast Cancer

Ombrabulin (AVE8062)

Phase 3

Ovarian Cancer Recurrent

efanesoctocog alfa (BIVV001)

Phase 3

Hemophilia A

Duvakitug

Phase 3

Ulcerative Colitis

xaliproden (SR57746A)

Phase 3

Alzheimer Disease

zolpidem-MR (SL800750)

Phase 3

Sleep Initiation and Maintenance Disorders

A/H1N1 pandemic influenza vaccine (non- adjuvanted)

Phase 3

Influenza

lactoserum

Phase 3

Hygiene

Docetaxel

Phase 3

Stomach Neoplasms

DTaP-IPV-HB-PRP~T

Phase 3

Diphtheria

Yellow fever vaccine (live)

Phase 3

Yellow Fever Immunization

Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus

Phase 3

Dengue

epidoxorubicine, ciclophosphamide, methotrexate, fluorouracile

Phase 3

Breast Neoplasms

Low Dose (LD) RSVt vaccine

Phase 3

RSV Immunisation

Insulin glargine/lixisenatide fixed ratio combination

Phase 3

Type 2 Diabetes Mellitus

Fexofenadine

Phase 3

Seasonal Allergic Rhinitis

rimonabant (SR141716)

Phase 3

Obesity

alglucosidase alfa

Phase 3

Pompe Disease (Late-onset)

DTaP-IPV-Hep B-PRP~T vaccine (Batch 1)

Phase 3

Diphtheria

INSULIN GLARGINE/LIXISENATIDE HOE901/AVE0010

Phase 3

Type 2 Diabetes Mellitus

Lactic Acid

Phase 3

Hygiene

Saredutant succinate (SR48968C)

Phase 3

Depressive Disorder

Fitusiran

Phase 3

Hemophilia

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Phase 3

Meningococcal Meningitis

Riliprubart Prefilled Pen (PFP)

Phase 3

Polyneuropathy, Inflammatory Demyelinating, Chronic

Meningococcal polysaccharide diphtheria toxoid conjugate

Phase 3

Meningitis

Measles, combinations with mumps and rubella, live attenuated

Phase 3

Yellow Fever Immunization

rFIXFc

Phase 3

Hemophilia B

Rilzabrutinib

Phase 3

Immune Thrombocytopenia

Purified vero rabies vaccine - serum free - VRVg-2

Phase 3

Rabies

Insulin glargine

Phase 3

Diabetes Mellitus, Type 1

vinorelbine tartrate

Phase 3

Lung Cancer

avalglucosidase alfa

Phase 3

Glycogen Storage Disease Type II

Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine (MenACYW Conjugate vaccine)

Phase 3

Healthy Volunteers (Meningococcal Infection)

Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Dronedarone (SR33589)

Phase 3

Atrial Fibrillation

amibegron (SR58611A)

Phase 3

Major Depressive Disorders

Sarilumab SAR153191 (REGN88)

Phase 3

Juvenile Idiopathic Arthritis

Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)

Phase 3

Pulmonary Diseases

PCV21 vaccine

Phase 3

Pneumococcal Immunization

Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate vaccine)

Phase 3

Meningococcal Immunisation

Sarilumab

Phase 3

RA

LACTIC ACID(ND)

Phase 3

Hygiene

Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus

Phase 3

Dengue Fever

Influenza Virus Vaccine

Phase 3

Influenza

Alirocumab

Phase 3

Hypercholesterolemia

Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus

Phase 3

Tetanus

SAR153191 (REGN88)

Phase 3

Rheumatoid Arthritis

Insulin aspart

Phase 3

Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus

saredutant (SR48968)

Phase 3

Major Depressive Disorder

Amlitelimab

Phase 3

Dermatitis Atopic

sodium hyaluronate

Phase 3

Osteoarthritis of Shoulder

High-Dose Inactivated, Split-Virion Influenza Vaccine

Phase 3

Orthomyxoviridae Infection

Iniparib (SAR240550/BSI-201)

Phase 3

Solid Tumors

Aldurazyme

Phase 3

Mucopolysaccharidosis I

Ciclesonide (XRP1526)

Phase 3

Asthma

alemtuzumab

Phase 3

B Cell Chronic Lymphocytic Leukemia

Caplacizumab

Phase 3

Acquired Thrombotic Thrombocytopenic Purpura

Granulocyte-colony stimulating factor (G-CSF)

Phase 3

Non-Hodgkin's Lymphoma

eplivanserin (SR46349)

Phase 3

Sleep Initiation and Maintenance Disorders

Clopidogrel

Phase 3

Thrombosis

Lactic acid (Dermacid)

Phase 3

Healthy

Enoxaparin sodium

Phase 3

Venous Thromboembolism

INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010)

Phase 3

Type 2 Diabetes Mellitus

Dupilumab

Phase 3

Lichen Simplex Chronicus

SR58611A

Phase 3

Anxiety Disorders

Lixisenatide (AVE0010)

Phase 3

Diabetes Mellitus, Type 2

Tirapazamine

Phase 3

Head and Neck Squamous Cell Carcinoma

Granulocyte colony-stimulating factor plus plerixafor

Phase 3

Lymphoma, Non-Hodgkin

Saredutant

Phase 3

Generalized Anxiety

Irbesartan/Amlodipine (150/5mg)

Phase 3

Hypertension

Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate

Phase 3

Meningitis

Tolebrutinib

Phase 3

Primary Progressive Multiple Sclerosis

glimepiride

Phase 3

Type 2 Diabetes Mellitus

Basal Insulin

Phase 3

Diabetes Mellitus, Type 2

AVE7688

Phase 3

Hypertension

cisplatin

Phase 3

Nasopharyngeal Neoplasms

DTaP IPV HB PRP~T vaccine

Phase 3

Diphtheria

Vandetanib

Phase 3

Non-small Cell Lung Cancer

SR34006 (idraparinux sodium) Injection

Phase 3

Pulmonary Embolism

Inhaled corticosteroid (ICS) therapy

Phase 3

Asthma

Adacel® (Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis)

Phase 3

Diphtheria

DTaP-HB-PRP~T combined vaccine

Phase 3

Diphtheria

Alirocumab SAR236553 (REGN727)

Phase 3

Hypercholesterolaemia

Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine MenACYW Conjugate vaccine

Phase 3

Meningococcal Immunisation (Healthy Volunteers)

Lipid-Modifying Therapy (LMT)

Phase 3

Hypercholesterolemia

Insulin glargine/Lixisenatide

Phase 3

Type 2 Diabetes Mellitus

tirapazamine (SR259075)

Phase 3

Head and Neck Neoplasms

Insulin glulisine (HMR1964)

Phase 3

Diabetes, Type I

sutimlimab

Phase 3

Cold Agglutinin Disease

Itepekimab SAR440340

Phase 3

Chronic Obstructive Pulmonary Disease

Ramipril

Phase 3

Myocardial Ischemia

Poliomyelitis Vaccine inactivated

Phase 3

Poliomyelitis

somatropin

Phase 3

Fetal Growth Retardation

Nirsevimab

Phase 3

RSV Immunization

Dupilumab SAR231893

Phase 3

Chronic Spontaneous Urticaria

sevelamer carbonate (Renvela®) sevelamer hydrochloride (Renagel ®)

Phase 3

Chronic Kidney Disease

Euvax B®: Hepatitis B vaccine

Phase 3

Hepatitis B

XRP6976

Phase 3

Stomach Neoplasm

enoxaparin (XRP4563)

Phase 3

Hip Fractures

Sevelamer carbonate (Renvela®)

Phase 3

Kidney Diseases

Leucovorin

Phase 3

Pancreatic Neoplasms

Metformin

Phase 3

Type 2 Diabetes Mellitus

insulin glulisine

Phase 3

Diabetes Mellitus

SENNA+CASSIA

Phase 3

Constipation

High-Dose Quadrivalent Influenza Vaccine, (Zonal Purified, Split Virus) 2020-2021 Strains (QIV-HD)

Phase 3

Influenza Immunization

DTaP-HB-PRP~T vaccine

Phase 3

Diphtheria

DTaP-IPV-Hep B-PRP~T combined vaccine

Phase 3

Diphtheria

Eliglustat tartrate

Phase 3

Gaucher Disease, Type 1

tolevamer potassium-sodium (GT267-004)

Phase 3

Clostridium Enterocolitis

Teplizumab

Phase 3

Type 1 Diabetes Mellitus

FEX60/PE10

Phase 3

Rhinitis Allergic

escitalopram

Phase 3

Depressive Disorder

Moisturizers

Phase 3

Neurodermatitis

Inactivated, split-virion influenza vaccine

Phase 3

Orthomyxoviridae Infection

Vandetanib (SAR390530)

Phase 3

Differentiated Thyroid Cancer

Itepekimab (SAR440340)

Phase 3

Chronic Obstructive Pulmonary Disease

Quadrivalent Inactivated Influenza Vaccine (2016-2017 NH formulation), No Preservative

Phase 3

Influenza

Semuloparin Sodium

Phase 3

Venous Thromboembolism

GEMIGLIPTIN LS15-0444

Phase 3

Type 2 Diabetes Mellitus

Idrabiotaparinux sodium

Phase 3

Deep Venous Thrombosis

rFVIIIFc

Phase 3

Hemophilia A

RSVt vaccine

Phase 3

RSV Immunization

Oxaliplatin + 5-Fluorouracil/Leucovorin

Phase 3

Carcinoma, Hepatocellular

Investigational Quadrivalent Inactivated Influenza Vaccine, No Preservative

Phase 3

Influenza

DTaP-IPV combined vaccine

Phase 3

Pertussis

NPH human insulin

Phase 3

Diabetes Mellitus, Type 2

Insulin glargine (HOE901)

Phase 3

Type 2 Diabetes Mellitus

CELIVARONE (SSR149744C)

Phase 3

Atrial Fibrillation

Atorvastatin

Phase 3

Hypercholesterolemia

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap (ADACEL)

Phase 3

Diphtheria

Docetaxel, Cisplatin, 5-fluorouracil (5-FU), radiotherapy

Phase 3

Head and Neck Neoplasms

Meningococcal polysaccharide groups A, C, W-135 and Y Conjugate vaccine

Phase 3

Meningitis

Isatuximab SAR650984

Phase 3

Multiple Myeloma

Bortezomib

Phase 3

Plasma Cell Myeloma

Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine

Phase 3

Meningitis

Hexaxim®

Phase 3

Diphtheria

gemcitabine/Eloxatin (GEMOX)

Phase 3

Carcinoma, Non-Small-Cell Lung

Insulin glargine (U300)

Phase 3

Type 2 Diabetes Mellitus

Tocilizumab

Phase 3

Rheumatoid Arthritis

PVRV

Phase 3

Rabies

ChimeriVax™-JE

Phase 3

Japanese Encephalitis

Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant.

Phase 3

Dengue Fever

Bacillus Clausii

Phase 3

Gastroenteritis

Dermacyd Breeze Pocket BR (Lactic Acid)

Phase 3

Hygiene

Tritanrix-HepB/Hib

Phase 3

Diphtheria

riferminogene pecaplasmid

Phase 3

Peripheral Vascular Diseases

Quadrivalent Influenza Vaccine

Phase 3

Influenza

Levofloxacin

Phase 3

Prostatitis

XRP0038 (NV1FGF)

Phase 2

Peripheral Arterial Disease

Haemophilus Influenzae Type b (Hib) vaccine

Phase 2

Meningitis

SSR240600C

Phase 2

Overactive Bladder

Rilzabrutinib dose 1

Phase 2

Graves' Disease

ChimeriVax-WN02 vaccine

Phase 2

West Nile Fever

Isatuximab intravenous (IV)

Phase 2

Plasma Cell Myeloma

CYD dengue vaccine serotypes (1, 2, 3, 4).

Phase 2

Dengue Virus

SL650472, Clopidogrel

Phase 2

Intermittent Claudication

bsi-201 plus temozolomide

Phase 2

Glioblastoma

Doxorubicin

Phase 2

Breast Neoplasms

Best Supportive Care

Phase 2

Carcinoma, Hepatocellular

G-CSF Plus Plerixafor

Phase 2

Hodgkin's Disease

SAR443122

Phase 2

Colitis Ulcerative

ILX651

Phase 2

Melanoma

Chimeric dengue serotype (1, 2, 3, 4)

Phase 2

Dengue

recombinant human acid alpha-glucosidase (rhGAA)

Phase 2

Pompe Disease

AVE0657

Phase 2

Sleep Apnea, Obstructive

RSV vaccine candidate

Phase 2

Respiratory Syncytial Virus Infection

CABAZITAXEL (XRP6258)

Phase 2

Prostatic Neoplasms

clofarabine

Phase 2

Acute Lymphoblastic Leukemia

Plerixafor (AMD3100)

Phase 2

Lymphoma

Yellow fever vaccine

Phase 2

Yellow Fever

SAR441344 IV

Phase 2

Systemic Lupus Erythematosus

Belumosudil 200 mg QD

Phase 2

Chronic Graft-versus-host-disease

Live attenuated Japanese encephalitis virus; Yellow fever virus

Phase 2

Japanese Encephalitis

Insulin glargine /lixisenatide Fixed Ratio Combination

Phase 2

Type 2 Diabetes Mellitus

larotaxel

Phase 2

Breast Cancer

A/C/Y/W-135, Meningococcal Polysaccharide Vaccine (Menomune®)

Phase 2

Meningitis

Oxaliplatin, Paclitaxel

Phase 2

Neoplasms, Germ Cell and Embryonal

oxaliplatine / gemcitabine / Vinorelbine

Phase 2

Non Small Cell Lung Cancer

Cabazitaxel XRP6258

Phase 2

Prostate Cancer

2009-2010 Trivalent Influenza Virus Vaccine

Phase 2

Influenza

Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate

Phase 2

Meningitis

Quadrivalent Inactivated Influenza High Dose

Phase 2

Influenza Immunization

Isatuximab

Phase 2

Plasma Cell Myeloma Refractory

Short-Acting Beta Agonists (SABA)

Phase 2

Asthma

ZD6474

Phase 2

Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line

Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC

Phase 2

Diphtheria

INIPARIB + irinotecan

Phase 2

Estrogen Receptor Negative (ER-Negative) Breast Cancer

Sevelamer hydrochloride

Phase 2

Chronic Kidney Disease

Fludarabine Phosphate (Fludara)

Phase 2

Lymphoma

HP184

Phase 2

Spinal Cord Injury

ALX-0061

Phase 2

Lupus Erythematosus, Systemic

VEGF-receptor tyrosine kinase (KDR)

Phase 2

Multiple Myeloma

Olipudase alfa

Phase 2

Niemann-Pick Disease

G-CSF and plerixafor

Phase 2

Lymphoma, Non-Hodgkin

Smallpox vaccine, LISTER strain, from chick embryo cells

Phase 2

Smallpox

Inactivated types 1, 2, and 3 poliovirus, D antigens

Phase 2

Poliomyelitis

High-dose quadrivalent influenza virus vaccine

Phase 2

Influenza

Swine A/H1N1 influenza vaccine (split virion, inactivated)

Phase 2

Influenza

Tdap vaccine

Phase 2

Dermatitis Atopic

Zemaira

Phase 2

Alpha 1-Antitrypsin Deficiency

AVE1625

Phase 2

Alzheimer Disease

SAR100842

Phase 2

Systemic Sclerosis

ATN-103 10 mg q4wks

Phase 2

Rheumatoid Arthritis

A/H5N1 inactivated, split-virion influenza virus

Phase 2

Influenza

Inactivated influenza vaccine (split virion) NH 2007-2008 formulation

Phase 2

Influenza

Yellow Fever

Phase 2

Dengue

SR31747A

Phase 2

Prostatic Neoplasm

Chlamydia mRNA Vaccine

Phase 2

Chlamydia Trachomatis Immunization

SSR149415

Phase 2

Depressive Disorder

Inactivated, split-virion influenza virus

Phase 2

Influenza

Belumosudil (KD025)

Phase 2

Graft vs Host Disease

surinabant (SR147778)

Phase 2

Smoking Cessation

Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1

Phase 2

Tetanus

SSR411298

Phase 2

Major Depressive Disorder

Quadrivalent Influenza mRNA Vaccine MRT5421

Phase 2

Influenza Immunization

Live attenuated Japanese encephalitis virus

Phase 2

Japanese Encephalitis

Oxaliplatin, capecitabine

Phase 2

Rectal Neoplasms

SAR440340

Phase 2

Asthma

SAR442970

Phase 2

Crohn's Disease

GT160-246

Phase 2

Clostridium Difficile-Associated Diarrhea

SAR292833

Phase 2

Neuropathic Pain

oxaliplatin, 5 FU

Phase 2

Endometrial Cancer

Fluzone: Influenza virus vaccine

Phase 2

Influenza

Fixed-dose combination of capecitabine and cyclophosphamide SAR439281

Phase 2

Breast Cancer Metastatic

(ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis

Phase 2

Pertussis

Etoposide

Phase 2

Acute Lymphoblastic Leukemia

XL147 (SAR245408)

Phase 2

Endometrial Cancer

Rasburicase (SR29142)

Phase 2

Hyperuricemia

Mitoguazone

Phase 2

Lymphoma, Non-Hodgkin

FOLFIRI

Phase 2

Colorectal Cancer

Allogeneic DCs and Autologous RCC Tumor Derived Cells

Phase 2

Carcinoma, Renal Cell

CYD Dengue Vaccine Serotypes 1, 2, 3, and 4

Phase 2

Dengue Virus

QIV-HD by IM

Phase 2

Influenza

Glucocorticoids

Phase 2

Immunoglobulin G4 Related Disease

Interferon-β-1

Phase 2

Multiple Sclerosis

Quadrivalent Meningococcal Polysaccharide (A, C, Y, and W-135) Tetanus Protein Conjugate

Phase 2

Meningitis

Vandetanib (ZD6474)

Phase 2

Advanced Breast Cancer

Alemtuzumab plus Fludarabine

Phase 2

Leukemia, Lymphocytic, Chronic, B-Cell

ATN-103

Phase 2

Rheumatoid Arthritis

XL765 (SAR245409)

Phase 2

Breast Cancer

SAR446268

Phase 2

Myotonic Dystrophy

docetaxel and cisplatin

Phase 2

Ovarian Neoplasms

RSV vaccine formulation 1

Phase 2

Respiratory Syncytial Virus Infection

ZD1839

Phase 2

Carcinoma, Non-Small-Cell Lung

Sotagliflozin (SAR439954)

Phase 2

Diabetes Mellitus

Liraglutide

Phase 2

Type 2 Diabetes Mellitus

SAR445399

Phase 2

Hidradenitis Suppurativa

Purified Vero Rabies Vaccine (VRVg)

Phase 2

Rabies

SAR407899

Phase 2

Erectile Dysfunction

ZD6474, Vandetanib

Phase 2

Biliary Tract Cancer

High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)

Phase 2

Influenza

Purified Vero Rabies Vaccine (VRVg) - Serum Free

Phase 2

Rabies

Oxaliplatin, 5-Fluorouracil

Phase 2

Stomach Neoplasms

Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]

Phase 2

Renal Transplantation

Purified Vero Rabies Vaccine Serum Free (VRVg)

Phase 2

Rabies

High-Dose Trivalent Inactivated Influenza Vaccine

Phase 2

Influenza

Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis

Phase 2

Dengue

Quadrivalent Influenza mRNA Vaccine MRT5407

Phase 2

Influenza Immunization

Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1)

Phase 2

Influenza

Iniparib

Phase 2

Primary Peritoneal Cancer

Docetaxel + Oxaliplatin

Phase 2

Stomach Neoplasms

Cemiplimab REGN2810

Phase 2

Plasma Cell Myeloma

ALX-0081

Phase 2

Unstable Angina

Celivarone

Phase 2

Arrhythmia Prophylaxis

Influenza virus (split virion, inactivated) vaccine

Phase 2

Influenza

Zactima (vandetanib)

Phase 2

Prostate Cancer

IIV-HD

Phase 2

COVID-19 Immunization

ataciguat (HMR1766)

Phase 2

Intermittent Claudication

Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28)

Phase 2

Japanese Encephalitis

Advate (Low Dose)

Phase 2

Hemophilia A

SSR180575

Phase 2

Diabetic Neuropathies

Inactivated, split-virion, influenza virus

Phase 2

Orthomyxoviridae Infections

Acne mRNA vaccine

Phase 2

Acne

Dupilumab SAR231893/REGN668

Phase 2

Asthma

GZ389988

Phase 2

Osteoarthritis

Oxaliplatin + cisplatin + 5-Fluorouracil (5-FU)

Phase 2

Esophageal Neoplasms

PRN473 (SAR444727)

Phase 2

Atopic Dermatitis

Meningococcal Polysaccharide (A, C, Y, and W 135) Tetanus Protein Conjugate Vaccine

Phase 2

Meningitis

Docetaxel, cisplatin and 5-FU treatment followed by concomitant cisplatin, 5-FU and radiotherapy

Phase 2

Head and Neck Neoplasms

CYD Dengue Vaccine (5 dose formulation)

Phase 2

Dengue Fever

satavaptan (SR121463B)

Phase 2

Ascites

Yellow fever vaccine (produced on serum-free Vero cells)

Phase 2

Yellow Fever

ferroquine (SSR97193)

Phase 2

Malaria

aflibercept

Phase 2

Colorectal Neoplasms

SAR444836

Phase 2

Phenylketonuria

Pneumococcal Conjugate Vaccine - formulation 1-SP0202-IIb

Phase 2

Pneumococcal Immunization

A/H5N1 Inactivated, split-virion pandemic influenza vaccine

Phase 2

Influenza

MVA Smallpox vaccine

Phase 2

Smallpox

Clostridium difficile Toxoid Vaccine

Phase 2

Clostridium Difficile Infection

plerixafor GZ316455

Phase 2

Multiple Myeloma

Vandetanib 300mg

Phase 2

Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma

teplizumab 1 mg/mL

Phase 2

Diabetes Mellitus, Type 1

GZ402665

Phase 2

Sphingomyelin Lipidosis

MRrhTSH

Phase 2

Multinodular Goiter

ALX-0171

Phase 2

Respiratory Syncytial Virus Infection

Quadrivalent Influenza mRNA Vaccine MRT5413

Phase 2

Influenza Immunization

SSR125543

Phase 2

Major Depression

Interferon beta-1a

Phase 2

Multiple Sclerosis, Relapsing-Remitting

Pandemic flu H5 HA mRNA SD2 vaccine

Phase 2

Pandemic Influenza Immunization

ICS/LABA therapy

Phase 2

Asthma

Docetaxel and Gemcitabine

Phase 2

Non-small Cell Lung Cancer

Dexamethasone

Phase 2

Hematological Malignancy

Pandemic flu H5 mRNA vaccine

Phase 2

Influenza Immunization

Trilostane

Phase 2

Prostate Cancer

Docetaxel and cisplatin followed by gemcitabine

Phase 2

Carcinoma, Non-Small-Cell Lung

SAR444336

Phase 2

Microscopic Colitis

XRP9881

Phase 2

Breast Cancer

Laronidase

Phase 2

Mucopolysaccharidosis I

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Phase 2

Meningitis

PRV-015

Phase 2

Celiac Disease

Isatuximab SC-OBDS

Phase 2

Plasma Cell Myeloma Refractory

Live attenuated Japanese encephalitis virus, then ChimeriVax diluent

Phase 2

Encephalitis

SAR245408

Phase 2

Neoplasm Malignant

fresolimumab

Phase 2

Primary Focal Segmental Glomerulosclerosis

SAR402663

Phase 2

Neovascular Age-related Macular Degeneration

Fetal porcine cells, Neurocell-PD

Phase 2

Parkinson's Disease

SSR149744C

Phase 2

Arrhythmia

SAR156597

Phase 2

Idiopathic Pulmonary Fibrosis

Docetaxel + CDDP

Phase 2

Carcinoma, Squamous Cell

SR57667B

Phase 2

Alzheimer Disease

Enteric coated sevelamer

Phase 2

Hypercholesterolemia

SAR446597

Phase 2

Geographic Atrophy

Influenza virus vaccine 2009-2010 formulation

Phase 2

Influenza

DOCETAXEL(XRP6976)

Phase 2

Head and Neck Neoplasms

Sargramostim (Leukine)

Phase 2

Crohn Disease

Inactivated rabies virus vaccine

Phase 2

Dengue Virus

SL77.0499-10 (alfuzosin hydrochloride)

Phase 2

Benign Prostatic Hyperplasia

Pentavalent Meningococcal ABCYW vaccine

Phase 2

Meningococcal Immunization

Live, attenuated, recombinant dengue serotype 1, 2, 3, 4 virus

Phase 2

Dengue

SAR425899

Phase 2

Type 2 Diabetes Mellitus

Split, Inactivated, Trivalent Influenza Vaccine

Phase 2

Orthomyxoviridae Infection

SR147778

Phase 2

Obesity

ChimeriVax™-JE vaccine

Phase 2

Japanese Encephalitis

SAR447537

Phase 2

Alpha 1-Antitrypsin Deficiency

SAR441566

Phase 2

Crohn's Disease

Menomune®: A, C, Y, W-135 Meningococcal Polysaccharide

Phase 2

Meningococcal Infections

SAR441344

Phase 2

Sjögren's Syndrome

Tesevatinib

Phase 2

Autosomal Dominant Polycystic Kidney

ALX-0171 3.0 mg/kg

Phase 2

Respiratory Syncytial Virus Lower Respiratory Tract Infection

Inactivated, split-virion, influenza vaccine

Phase 2

Influenza

BSI-201

Phase 2

Ovarian Cancer

Nerispirdine

Phase 2

Multiple Sclerosis

RIV (recombinant influenza vaccine)

Phase 2

COVID-19 Immunization

Fabrazyme (agalsidase beta)

Phase 2

Fabry Disease

teriflunomide (HMR1726)

Phase 2

Multiple Sclerosis

Influenza virus vaccine - cell based (2007-2008 Formulation)

Phase 2

Influenza

Regulatory & News

Approvals, filings, and latest developments

Regulatory Approvals
SNY News